COMMUNIQUÉS West-GlobeNewswire
 
      -   
  IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 27 - 202508/07/2025
-   
  Report on Carbios’ liquidity contract with Natixis ODDO BHF08/07/2025
-   
  CARBIOS : Bilan semestriel du contrat de liquidité confié à Natixis ODDO BHF08/07/2025
-   
  BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE S1 202508/07/2025
-   
  GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 juin 202508/07/2025
-   
  Dr. Anosh Ahmed Expands Global Healthcare Leadership Through New Community Health Initiative08/07/2025
-   
  Capsa Healthcare Unveils Industry’s First Consolidated Services Pharmacy Platform08/07/2025
-   
  Corza Medical annonce le lancement de la gamme élargie de sutures ophtalmiques Onatec08/07/2025
-   
  Vanderbilt’s Dr. Neal Patel Joins Heald as Strategic Advisor to Advance Human-Led Diabetes Reversal08/07/2025
-   
  Longeveron® Announces U.S. FDA Approval of IND Application for a Phase 2 Pivotal Registration Study Evaluating Laromestrocel as a Treatment of Pediatric Dilated Cardiomyopathy (DCM)08/07/2025
-   
  Courtney Caputo Named Chair of the National Board of Directors at the Epilepsy Foundation of America08/07/2025
-   
  Amarna Therapeutics and NorthX Biologics Finalize Agreement to Advance Nimvec™ AM510 Gene Therapy Toward Clinical Trials for Type 1 Diabetes08/07/2025
-   
  PathAI Launches Precision Pathology Network to Advance AI-Powered Pathology08/07/2025
-   
  Predictive Oncology Announces $10M Share Purchase Agreement in Partnership with Yorkville Advisors to Advance AI-Driven Drug Discovery and Repurposing08/07/2025
-   
  Privia Health Announces Appointment of Lance V. Berberian to its Board of Directors08/07/2025
-   
  Greenspace Leads Scientific Revival of Ayurveda With New Quantum-Based Approach08/07/2025
-   
  BiomX Announces Publication in Nature Communications of Phage Cocktail BX004 Phase 1b/2a Part 1 Data Demonstrating Strong Activity in Cystic Fibrosis08/07/2025
-   
  Calidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision Genetic Medicine Platform for Cancer Treatment08/07/2025
-   
  Clover Health to Report Second Quarter 2025 Financial Results on August 5, 202508/07/2025
Pages